Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized ...
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
According to the core tenets of the Wim Hof Method, exposure to extreme cold ignites a "cascade of health benefits." Getty Images/iStockphoto New York Post may be compensated and/or receive an ...
IceCure Medical Ltd. announced positive top-line results from its ICESECRET clinical trial of its ProSense cryoablation ...
IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...
ORLANDO -- Cryoablation without excision for low-risk, early-stage breast cancer may be an option for women over 60, 5-year follow-up results from the ICE3 trial showed. At a mean follow-up of 54.2 ...
BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
Lucia Gaitan, M.D., FACOG, Lucia Gaitan, M.D., FACOG MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- In a release issued under the ...
Cryo-focused ion beam (cryo-FIB) milling is indispensable for preparing thin lamellae from thick biological samples for cryo-electron tomography (cryo-ET), especially at the tissue level. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results